AUTHOR=Duan Jun , Zeng Jia , Deng Puyu , Ni Zhong , Lu Rongli , Xia Wenxi , Jing Guoqiang , Su Xiaoping , Ehrmann Stephan , Zhang Wei , Li Jie 

TITLE=High-Flow Nasal Cannula for COVID-19 Patients: A Multicenter Retrospective Study in China

JOURNAL=Frontiers in Molecular Biosciences

VOLUME=8

YEAR=2021

URL=https://www.frontiersin.org/journals/molecular-biosciences/articles/10.3389/fmolb.2021.639100

DOI=10.3389/fmolb.2021.639100

ISSN=2296-889X

ABSTRACT=<p><bold>Background:</bold> High-flow nasal cannula (HFNC) may help avoid intubation of hypoxemic patients suffering from COVID-19; however, it may also contribute to delaying intubation, which may increase mortality. Here, we aimed to identify the predictors of HFNC failure among patients with COVID-19.</p><p><bold>Methods:</bold> We performed a multicenter retrospective study in China from January 15 to March 31, 2020. Two centers in Wuhan (resource-limited centers) enrolled 32 patients, and four centers outside Wuhan enrolled 34 cases. HFNC failure was defined as the requirement of escalation therapy (NIV or intubation). The ROX index (the ratio of SpO<sub>2</sub>/FiO<sub>2</sub> to the respiratory rate) was calculated.</p><p><bold>Results:</bold> Among the 66 patients, 29 (44%) cases experienced HFNC failure. The ROX index was much lower in failing patients than in successful ones after 1, 2, 4, 8, 12, and 24 h of HFNC. The ROX index was independently associated with HFNC failure (OR = 0.65; 95% CI: 0.45–0.94) among the variables collected before and 1 h after HFNC. To predict HFNC failure tested by ROX index, the AUC was between 0.73 and 0.79 for the time points of measurement 1–24 h after HFNC initiation. The HFNC failure rate was not different between patients in and outside Wuhan (41% vs. 47%, <italic>p</italic> = 0.63). However, the time from HFNC initiation to intubation was longer in Wuhan than that outside Wuhan (median 63 vs. 22 h, <italic>p</italic> = 0.02). Four patients in Wuhan underwent intubation due to cardiac arrest; in contrast, none of the patients outside Wuhan received intubation (13 vs. 0%, <italic>p</italic> = 0.05). The mortality was higher in Wuhan than that out of Wuhan, but the difference did not reach statistical significance (31 vs. 12%, <italic>p</italic> = 0.07).</p><p><bold>Conclusion:</bold> The ROX index can be used to predict HFNC failure among COVID-19 patients to avoid delayed intubation, which may occur in the resource-limited area.</p>